Cartesian Therapeutics, Inc. — Director's Dealing 2016

Jun 22, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21

Reporting Person: RUSNANO (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	49866	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series D Convertible Preferred Stock	$		Common Stock (799915)		Direct
Series SRN Convertible Preferred Stock	$		Common Stock (208705)		Direct
Series E Convertible Preferred Stock	$		Common Stock (200338)		Direct
Warrant (right to buy)	$17.55	2018-07-24	Common Stock (13103)		Direct

Footnotes

F1: 2,981,019 outstanding shares of Series D Preferred Stock are currently convertible into 799,915 shares of Common Stock.

F2: Not applicable.

F3: 777,777 outstanding shares of Series SRN Convertible Preferred Stock are currently convertible into 208,705 shares of Common Stock.

F4: 781,322 outstanding shares of Series E Preferred Stock are currently convertible into 200,338 shares of Common Stock.